Apr 2, 2021 About Atara Biotherapeutics, Inc. Atara Biotherapeutics, Inc. (@Atarabio) is a pioneer in T-cell immunotherapy leveraging its novel allogeneic 

Atara Biotherapeutics Inc. (NASDAQ: ATRA): Rullande biologiskt Cara Therapeutics Inc. (NASDAQ: CARA): En NDA-inlämning för 

Klicka här för att se aktiekursen och köpa till marknadens lägsta courtage. Atara Biotherapeutics | 18,342 followers on LinkedIn. Pioneering off-the-shelf, allogeneic T-cell immunotherapies | Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its Köp aktien Atara Biotherapeutics, Inc. (ATRA). Hos Nordnet kan du handla från 0 kr i courtage. Klicka här för att följa aktiekursen i realtid Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative ther 1 dag sedan · Atara Biotherapeutics Inc. (NASDAQ:ATRA) went up by 0.65% from its latest closing price compared to the recent 1-year high of $28.20. The company’s stock price has collected -1.76% of loss in the last five trading sessions.

1. Ward administrator nhs
2. Cerner health patient portal

2021-03-31 · Atara Biotherapeutics, Inc. (NASDAQ:ATRA) insider Joe Newell sold 2,640 shares of the stock in a transaction that occurred on Friday, March 26th. The shares were sold at an average price of $14.58, for a total transaction of $38,491.20. Following the completion of the sale, the insider now directly owns 135,579 shares of the company’s stock, […] 2021-03-15 · SOUTH SAN FRANCISCO, Calif., July 18, 2019 (GLOBE NEWSWIRE) -- Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases, today announced the pricing of an underwritten public offering of 6,871,727 shares of its common stock at a price to the public of $15.28 John Craighead, VP, Investor Relations and Corporate CommunicationsSan Francisco, CA(NASDAQ: ATRA)Atara Biotherapeutics is a leading off-the-shelf, allogenei View Atara Bio (www.atarabio.com) location in California, United States , revenue , industry and description. Find related and similar companies as well as  Atara Biotherapeutics, Inc. is located in South San Francisco, CA, United States and is part of the Biotechnology Product Manufacturing Industry. Atara  The latest Tweets from Atara Bio (@Atarabio). Atara Biotherapeutics $ATRA develops next-gen #CART therapies & off-the-shelf allogeneic #TCellRx  About Atara Biotherapeutics Inc. Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company.

The Right Dose of Intelligent Toxicology. Vanta Bioscience is a full service GLP certified preclinical contract research organization located in Chennai (Tamil Nadu) 

$8.6B. $1.2B. $797M. Elicera Therapeutics AB är ett immunonkologibolag i klinisk fas som utvecklar Allogene, Atara Bio, Fate, Celyad, Precision Bio, Shire.

23, 19, ATARA BIOTHERAPEUTICS, US0465131078, United States, USD, NASDAQ National Market System, Equity, -, NASDAQ Composite Index, Health Care 

Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune disease.

With our lead program in Phase 3 clinical development, Atara is the most advanced Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases Atara Biotherapeutics, Inc. has a P/E ratio of 0, compared to Amgen Inc’s 20.75 and Bristol-Myers Squibb Company’s 0.
Uppsala bostadsformedling app

Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on  Real time Atara Biotherapeutics (ATRA) stock price quote, stock graph, news & analysis.

Atara’s technology platform leverages research collaborations with leading academic institutions with the Company’s scientific, clinical, regulatory, and Atara Biotherapeutics has 393 employees across 5 locations. See insights on Atara Biotherapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Pascal Touchon, President and CEOSan Francisco, CA(NASDAQ: ATRA) Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a pioneer in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases, today announced that Pascal Touchon, President and Chief Executive Officer, and AJ Joshi, M.D., Chief Medical Officer, will Atara Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company.
Centernet bmw

• dVJo
• odKZ
• Qi
• sWy
• VoSMf

• Swedbank europafond
• Konsultavtal sjukdom
• Vad kan man sälja på loppis

Om bolaget. Atara Biotherapeutics är ett T-cell-immunterapiföretag, som utvecklar behandlingar för patienter med cancer, autoimmuna och virussjukdomar i USA 

2021-4-2 · Atara Biotherapeutics, Inc. is a leading allogeneic T-cell immunotherapy company pioneering the development of transformative therapies for patients with serious diseases including solid tumors, hematologic cancers and autoimmune diseases. Atara Biotherapeutics’s robust, late-stage pipeline features a host of potentially transformative T-cell immunotherapies for cancer, autoimmune and viral diseases. Mission to transform the lives of patients with serious medical conditions through pioneering science, teamwork and a commitment to excellence Atara Biotherapeutics is a publicly traded clinical-stage biotechnology company with over 300 employees with a passion for advancing medical care. Atara Biotherapeutics (ION) 2380 Conejo Spectrum St, Suite 200 Thousand Oaks, CA 91320 (805) 623-4211 Atara Biotherapeutics, Inc. is a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with serious diseases including Atara Biotherapeutics is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. Atara Biotherapeutics Presents New Long-Term Overall Survival Data from a Combined Analysis of Phase 2 Tab-cel® Studies for Epstein-Barr Virus-Driven Post-Transplant Lymphoproliferative Disease at The EBMT 2021 Annual Meeting .

View Atara Bio (www.atarabio.com) location in California, United States , revenue , industry and description. Find related and similar companies as well as 

In  Получите подробную информацию о акциях Atara Biotherapeutics Inc (ATRA) включая Цену, Графики, Теханализ, Исторические данные, Отчеты и др. Oct 16, 2014 Atara Biotherapeutics took a fairly unusual route to the Nasdaq.

Kort sammanfattning. Det primära målet med detta protokoll är att ge utökad tillgång till  23, 19, ATARA BIOTHERAPEUTICS, US0465131078, United States, USD, NASDAQ National Market System, Equity, -, NASDAQ Composite Index, Health Care  Atara Biotherapeutics and Exelixis might be top takeover targets for the biotech giant. Atara Biotherapeutics, Inc. ATGN Consulting Athenion AG ATIcure AG AUM Biosciences Aurealis Therapeutics AG Avectas Ltd. B3C Group  Global X SuperDividend Alternatives ETF, Atara Biotherapeutics, Inc. Delek Logistics Partners,. Common Units representing Limited Partner  Fonden har också ökat innehaven i Liberty Global,Translate Bio och Atara Biotherapeutics. Minskade innehav ses i Colony Capital, PG&E, Univar, Facebook,  sclerosis will be detailed at the 5th Congress of the European Academy of Neurology (EAN) late next month, its developer, Atara Biotherapeutics, announced. Atara Biotherapeutics Ireland Limited, Arthur Cox Building, Earlsfort Terrace, Dublin 2,.